ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,382Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 197

$678K Total Retail Price of All Prescriptions

Rank: 27 out of 197

395 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

3% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

4% of this provider’s 1,675 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ZOLPIDEM TARTRATE 350 107 1 11
TRAZODONE HCL 309 127 2 1
RISPERIDONE 256 90 3 2
QUETIAPINE FUMARATE 223 48 4 3
SERTRALINE HCL 220 68 5 7
DIVALPROEX SODIUM ER 187 45 6 6
ESCITALOPRAM OXALATE 187 59 6 15
ALPRAZOLAM 183 31 8 44
MIRTAZAPINE 179 86 9 9
FLUOXETINE HCL 174 48 10 12
BENZTROPINE MESYLATE 162 22 R 11 4
CYMBALTA 161 47 12 5
AMPHETAMINE SALT COMBO 146 0 S2 13 45
SEROQUEL XR 129 16 14 22
CLONAZEPAM 126 34 15 39
PRISTIQ ER 121 30 16 36
TEMAZEPAM 119 28 17 106
VENLAFAXINE HCL ER 108 32 18 14
CITALOPRAM HBR 103 27 19 8
AMITRIPTYLINE HCL 101 37 R 20 38
ABILIFY 85 45 21 10
LUNESTA 82 16 22 73
DOXEPIN HCL 81 16 23 48
SEROQUEL 80 25 24 17
GABAPENTIN 78 11 25 31
LAMOTRIGINE 74 22 26 16
LITHIUM CARBONATE 69 44 27 18
CLOZAPINE 63 0 28 28
OXCARBAZEPINE 61 0 29 30
HALOPERIDOL 59 12 30 23
BUPROPION XL 56 0 31 19
ZIPRASIDONE HCL 55 0 32 24
LEXAPRO 53 21 33 51
LATUDA 52 0 34 56
INVEGA 52 0 34 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.